LV12491B - Farmaceitiska kompozīcija - Google Patents

Farmaceitiska kompozīcija Download PDF

Info

Publication number
LV12491B
LV12491B LVP-98-252A LV980252A LV12491B LV 12491 B LV12491 B LV 12491B LV 980252 A LV980252 A LV 980252A LV 12491 B LV12491 B LV 12491B
Authority
LV
Latvia
Prior art keywords
enalapril
mildronate
pharmaceutical composition
myocardial infarction
animals
Prior art date
Application number
LVP-98-252A
Other languages
English (en)
Latvian (lv)
Other versions
LV12491A (en
Inventor
Ivars KALVIŅŠ
Māris VĒVERIS
Juris BUNDULIS
Ilze SKĀRDA
Original Assignee
Ivars KALVIŅŠ
Māris VĒVERIS
Juris BUNDULIS
Ilze SKĀRDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars KALVIŅŠ, Māris VĒVERIS, Juris BUNDULIS, Ilze SKĀRDA filed Critical Ivars KALVIŅŠ
Priority to LVP-98-252A priority Critical patent/LV12491B/lv
Priority to PCT/LV1999/000005 priority patent/WO2000025773A1/en
Priority to EA200100477A priority patent/EA003470B1/ru
Priority to EP99949439A priority patent/EP1124547A1/en
Priority to UA2001053571A priority patent/UA71934C2/uk
Publication of LV12491A publication Critical patent/LV12491A/xx
Publication of LV12491B publication Critical patent/LV12491B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LVP-98-252A 1998-10-29 1998-10-29 Farmaceitiska kompozīcija LV12491B (lv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
LVP-98-252A LV12491B (lv) 1998-10-29 1998-10-29 Farmaceitiska kompozīcija
PCT/LV1999/000005 WO2000025773A1 (en) 1998-10-29 1999-10-27 Pharmaceutical combination of mildronate and enalapril
EA200100477A EA003470B1 (ru) 1998-10-29 1999-10-27 Фармацевтическая композиция тгп и ингибитора апф
EP99949439A EP1124547A1 (en) 1998-10-29 1999-10-27 Pharmaceutical combination of mildronate and enalapril
UA2001053571A UA71934C2 (en) 1998-10-29 1999-10-27 Pharmaceutical composition containing 3-(2,2,2-trimethyldrazinium) propionate and angiotensin converting enzyme inhibitor and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-98-252A LV12491B (lv) 1998-10-29 1998-10-29 Farmaceitiska kompozīcija

Publications (2)

Publication Number Publication Date
LV12491A LV12491A (en) 2000-06-20
LV12491B true LV12491B (lv) 2000-12-20

Family

ID=19736545

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-252A LV12491B (lv) 1998-10-29 1998-10-29 Farmaceitiska kompozīcija

Country Status (5)

Country Link
EP (1) EP1124547A1 (ru)
EA (1) EA003470B1 (ru)
LV (1) LV12491B (ru)
UA (1) UA71934C2 (ru)
WO (1) WO2000025773A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
EP2420224A1 (en) * 2010-08-11 2012-02-22 Grindeks, a joint stock company Method for producing a stable 3-(2,2,2-trimethylhydrazinium)propionate dihydrate solid pharmaceutical composition
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью
CN105853349A (zh) * 2016-04-29 2016-08-17 济南康和医药科技有限公司 一种米屈肼注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
EP1124547A1 (en) 2001-08-22
UA71934C2 (en) 2005-01-17
WO2000025773A1 (en) 2000-05-11
EA200100477A1 (ru) 2001-10-22
EA003470B1 (ru) 2003-06-26
LV12491A (en) 2000-06-20

Similar Documents

Publication Publication Date Title
EP1437131B1 (en) Use of ramipril for the prevention of diabetes in a patient with no preexisting congestive heart failure
Neutel et al. Combination therapy with diuretics: an evolution of understanding
Ulvenstam et al. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study
Szucs Cilazapril: a review
Matsuo et al. Effects of an angiotensin II antagonist on reperfusion arrhythmias in dogs
LV12491B (lv) Farmaceitiska kompozīcija
US20050009899A1 (en) Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US20160101117A1 (en) Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency
KR100623166B1 (ko) 심부전 치료를 위한 코르티졸 길항제의 용도
US20170079953A1 (en) Melatonin and its use in preventing postoperative complications
RU2252754C2 (ru) Применение карипорида для уменьшения нежелательных воздействий макролидных антибиотиков при ишемии и реперфузии сердца
CN101467992A (zh) L-肉碱用于治疗心血管疾病的用途
Ogihara et al. Dose-effect relationship of carvedilol in essential hypertension: an open study
LV14268B (lv) Meldonija sukcinātu saturoši medicīniskie produkti
HU212941B (en) Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril
SK285428B6 (sk) Použitie (-)-[[4-(1,4,5,6-tetrahydro-4-metyl-6-oxo-3- pyridazinyl)fenyl]hydrazono]propándinitrilu na výrobu lieku na liečbu vazospazmu koronárneho štepu
US20180311241A1 (en) Pharmaceutical synergistic combination
RU2076711C1 (ru) Антиаритмический препарат
RU2421234C1 (ru) Композиция для профилактики и лечения хронической сердечно-сосудистой недостаточности
US20050059741A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1
UA67822C2 (ru) Моксонидин для лечения поражений сердечной мышцы при инфаркте миокарда, способ получения фармацевтической композиции
KR20040083498A (ko) 심부전증 및 기타 노화-관련된 기관의 기능장애,노화-관련 질환을 예방하고 생명을 연장하기 위한 ａｃｅ억제제와 나트륨-수소 교환 억제제 카리포리드와의 배합제제
WO1997040680A1 (en) Antioxidant compound